Andrew Spokes portfolio, Q3 2025

Farallon Capital Management · 13F for the quarter ending Sep 30, 2025

For Q3 2025, Farallon Capital Management reported $17.7B across 139 US-listed positions, led by MSFT (5.6%), AON (4.6%) and EXEL (4.6%). Compared with its filing for Q2 2025, Andrew Spokes opened 21 new positions, added to 35, reduced 33 and sold out of 25; 50 positions did not change.

The largest purchase was a new position in ETHA ($234.8M); the largest sale, the sale of the whole position in SPY ($3.4B).

Reported value
$17.7B
Positions
139
In the top 10
41%
Filed
Nov 14
2025

Key facts

13F portfolio value
$17.7BQ3 2025
Positions
139
Largest holding
MSFT 5.6%
New positions
21
Sold out
25
Filed
Nov 14, 2025

Holdings as of (Q3 2025), filed with the SEC on and amended on . Changes are measured against the filing for Jun 30, 2025. Every tracked investor's Q3 2025 13F.

Bought and sold in Q3 2025

Andrew Spokes: buys and sells in Q3 2025
StockMoveSharesSizeOf portfolio
SPDR S&P 500 ETFSPY▼ Sold out−5.5M$3.4B19.2%
Hess Corpno ticker on file
▼ Sold out−5.81M$804.2M4.54%
IQVIA Holdings IncIQV▼ Reduced 76%−2.91M$553.3M3.13%
Liberty Broadband Corpno ticker on file
▼ Sold out−4.27M$420.5M2.38%
ANSYS Incno ticker on file
▼ Sold out−997.13K$350.2M1.98%
iShares Ethereum Trust ETFETHA▲ New+7.45M$234.8M1.33%
Norfolk Southern CorpNSC▲ New+615K$184.8M1.04%
WabtecWAB▲ Added 69%+896.9K$179.8M1.02%
Kellanovano ticker on file
▲ Added 124%+2.18M$178.9M1.01%
Verona Pharma Plcno ticker on file
▼ Sold out−1.81M$171.2M0.97%
Azek Co Incno ticker on file
▼ Sold out−3.14M$170.7M0.96%
Lantheus Holdings IncLNTH▼ Reduced 48%−3.25M$166.4M0.94%
Alphabet IncGOOG▼ Reduced 36%−640.9K$156.1M0.88%
AramarkARMK▼ Reduced 30%−3.9M$149.9M0.85%
Hims & Hers Health IncHIMS▲ Added 31%+2.53M$143.7M0.81%
Exelixis IncEXEL▲ Added 22%+3.47M$143.1M0.81%
Championx Corporationno ticker on file
▼ Sold out−4.25M$105.4M0.60%
Aon PLCAON▲ Added 15%+291.6K$104M0.59%
Amazon.com IncAMZN▲ Added 16%+471.1K$103.4M0.58%
Teva Pharmaceutical IndustriesTEVA▲ New+5M$100.9M0.57%
Visa IncV▲ Added 94%+291K$99.3M0.56%
GE HealthCare Technologies IncGEHC▼ Reduced 100%−1.32M$99.1M0.56%
Liquidia CorporationLQDA▲ Added 102%+4.33M$98.4M0.56%
UnitedHealth Group IncUNH▲ Added 17%+269.2K$93M0.53%
Natera IncNTRA▼ Reduced 12%−568.36K$91.5M0.52%
Microsoft CorpMSFT▲ Added 9.5%+165.3K$85.6M0.48%
Salesforce IncCRM▲ Added 17%+353.2K$83.7M0.47%
CBRE Group IncCBRE▼ Reduced 24%−497.1K$78.3M0.44%
Boston Scientific CorpBSX▲ Added 19%+765.5K$74.7M0.42%
Woodward IncWWD▼ Reduced 32%−292.7K$74M0.42%
Abivax SAABVX▲ New+805K$68.3M0.39%
The Charles Schwab CorpSCHW▼ Reduced 18%−707.4K$67.5M0.38%
Mineralys Therapeutics IncMLYS▲ New+1.67M$63.4M0.36%
Thermo Fisher Scientific IncTMO▼ Reduced 9.0%−125K$60.6M0.34%
Amedisys Incno ticker on file
▼ Sold out−575K$56.6M0.32%
TransUnionTRU▼ Reduced 12%−672.5K$56.3M0.32%
Mara Holdings IncMARA▲ Added 338%+2.83M$51.6M0.29%
Grail IncGRAL▲ Added 169%+847K$50.1M0.28%
Grayscale Coindesk CryptoGDLC▲ New+851.19K$47.6M0.27%
Crinetics Pharmaceuticalsno ticker on file
▲ Added 24%+1.12M$46.8M0.26%
Nektar TherapeuticsNKTR▲ New+791K$45M0.25%
JD.com Incno ticker on file
▼ Sold out—$41.8M0.24%
Oscar Health IncOSCR▲ Added 147%+2.16M$40.9M0.23%
Nasdaq IncNDAQ▼ Reduced 11%−460.7K$40.7M0.23%
Verve Therapeutics Incno ticker on file
▼ Sold out−3.61M$40.6M0.23%
The Walt Disney CoDIS▲ Added 6.7%+324.7K$37.2M0.21%
New York Times Co MTN BeNYT▼ Reduced 11%−623.8K$35.8M0.20%
Mastercard IncMA▲ Added 41%+61.7K$35.1M0.20%
GeneDx Holdings CorpWGS▼ Reduced 98%−321.68K$34.7M0.20%
IntuitINTU▼ Reduced 9.1%−48.57K$33.2M0.19%
Uniqure NVQURE▲ Added more than 10×+551K$32.2M0.18%
Cardinal Health IncCAH▼ Reduced 44%−201K$31.5M0.18%
Assembly Biosciences IncASMB▲ New+1.23M$31.4M0.18%
New Oriental ED & TechnologyEDU▼ Reduced 51%−590K$31.3M0.18%
Healthequity IncHQY▼ Reduced 98%−314.8K$29.8M0.17%
Cidara Therapeutics Incno ticker on file
▲ Added 154%+308K$29.5M0.17%
Baidu IncBIDU▲ New+208K$27.4M0.15%
Doximity IncDOCS▲ New+374K$27.4M0.15%
Ultragenyx PharmaceuticalRARE▼ Reduced 99%−891K$26.8M0.15%
Autodesk IncADSK▼ Reduced 4.7%−81.8K$26M0.15%
Vnet Group IncVNET▲ Added 83%+2.5M$25.8M0.15%
Tenet Healthcare CorpTHC▼ Reduced 22%−115K$23.3M0.13%
Surgery Partners IncSGRY▼ Reduced 55%−1.05M$22.8M0.13%
Prime Medicine IncPRME▲ Added 533%+4M$22.2M0.13%
MR Cooper Group Incno ticker on file
▲ Added 81%+99.5K$21M0.12%
Alkermes PLCALKS▼ Reduced 97%−670.86K$20.1M0.11%
Abbott LabsABT▼ Sold out−136K$18.5M0.10%
Full Truck Alliance CoYMM▼ Sold out−1.55M$18.3M0.10%
Encompass Health CorpEHC▼ Reduced 19%−137K$17.4M0.10%
Paramount Globalno ticker on file
▼ Sold out−1.35M$17.4M0.10%
Schrodinger IncSDGR▼ Reduced 74%−822K$16.5M0.09%
Savara IncSVRA▼ Reduced 63%−4.34M$15.5M0.09%
Bridgebio Pharma IncBBIO▲ Added 3.7%+292K$15.2M0.09%
Revolution Medicines IncRVMD▲ Added 2.1%+300K$14M0.08%
Tango Therapeutics IncTNGX▲ Added 17%+1.6M$13.4M0.08%
Latam Airlines Group SALTM▼ Sold out−318.09K$12.9M0.07%
Nuvalent Incno ticker on file
▼ Reduced 98%−147K$12.7M0.07%
Globus Med IncGMED▼ Reduced 98%−206K$11.8M0.07%
Flutter Entertainment PLCFLUT▼ Reduced 24%−43.86K$11.1M0.06%
Intellia Therapeutics IncNTLA▲ New+607.2K$10.5M0.06%
Soleno Therapeutics Incno ticker on file
▲ Added more than 10×+148K$10M0.06%
Mckesson CorpMCK▲ Added 4.0%+12.5K$9.7M0.05%
JOYY IncJOYY▼ Reduced 21%−162.91K$9.5M0.05%
Analog Devices IncADI▲ Added 2.2%+27.3K$6.7M0.04%
Novavax IncNVAX▲ Added more than 10×+764K$6.6M0.04%
Helix Acquisition Corp IIHLXC▼ Sold out−600K$6.4M0.04%
Liberty Broadband Corpno ticker on file
▼ Sold out−58.22K$5.7M0.03%
Waystar Holding CorpWAY▲ Added 22%+137K$5.2M0.03%
iShares Trustno ticker on file
▲ New+18.91K$5.1M0.03%
Allete Incno ticker on file
▲ New+75K$5M0.03%
Centessa Pharmaceuticals PLCno ticker on file
▼ Reduced 4.4%−198K$4.8M0.03%
Tectonic Therapeutic IncTECX▼ Reduced 25%−213.05K$3.3M0.02%
Voyager Therapeutics IncVYGR▼ Sold out−715K$2.2M0.01%
Beta Bionics IncBBNX▲ Added 2.6%+110K$2.2M0.01%
iShares Bitcoin Trust ETFIBIT▼ Reduced 0.4%−27.35K$1.8M0.01%
Protagonist Therapeutics IncPTGX▲ Added 0.4%+24K$1.6M0.01%
Beam Therapeutics IncBEAM▲ Added 0.5%+50K$1.2M0.01%
Janux Therapeutics IncJANX▼ Sold out−48K$1.1M0.01%
Agios Pharmaceuticals IncAGIO▲ Added 0.2%+13.6K$545.9K0.00%
Sage Therapeutics Incno ticker on file
▼ Sold out−42.8K$390.3K0.00%
Ionis Pharmaceuticals IncIONS▲ New+4.8K$314K0.00%
United Therapeutics CorpUTHR▼ Sold out−1K$287.4K0.00%
Merus N Vno ticker on file
▲ New+3K$282.5K0.00%
Veracyte IncVCYT▲ New+7K$240.3K0.00%
Springworks Therapeutics Incno ticker on file
▼ Sold out−5K$235K0.00%
Mirum Pharmaceuticals IncMIRM▲ New+3K$219.9K0.00%
UroGen Pharma LtdURGN▲ New+11K$219.5K0.00%
Akero Therapeutics Incno ticker on file
▼ Sold out−4K$213.4K0.00%
Icon Pub Ltd CoICLR▲ New+1.2K$210K0.00%
Bruker CorpBRKR▼ Sold out−5K$206K0.00%
BioCryst Pharmaceuticals IncBCRX▲ New+24K$182.2K0.00%
Blue Gold Ltdno ticker on file
▲ New+300K$137.3K0.00%
Third Harmonic Bio Incno ticker on file
▼ Sold out−15.36K$83.4K0.00%
Biodesix IncBDSX▼ Sold out−128K$36.1K0.00%

Holdings at the quarter's end

Andrew Spokes holdings, Q3 2025
#StockSectorShare of portfolioValueSharesReported priceHeldSince Q2 2025
1Microsoft CorpMSFTTechnology5.60%$990.9M1.91M$517.955+ qtrs▲ Added 9.5%
2Aon PLCAON · SHS CL AFinancials4.59%$812.3M2.28M$356.585+ qtrs▲ Added 15%
3Exelixis IncEXELHealth Care4.55%$805.4M19.5M$41.305+ qtrs▲ Added 22%
4Amazon.com IncAMZNConsumer Discretionary4.35%$769.7M3.51M$219.572 qtrs▲ Added 16%
5Natera IncNTRAHealth Care3.87%$684.7M4.25M$160.975+ qtrs▼ Reduced 12%
6Revolution Medicines IncRVMDHealth Care3.86%$683M14.63M$46.705+ qtrs▲ Added 2.1%
7UnitedHealth Group IncUNHHealth Care3.68%$651.4M1.89M$345.305+ qtrs▲ Added 17%
8Thermo Fisher Scientific IncTMOHealth Care3.45%$610.3M1.26M$485.025+ qtrs▼ Reduced 9.0%
9Hims & Hers Health IncHIMSHealth Care3.44%$609.6M10.75M$56.725+ qtrs▲ Added 31%
10The Walt Disney CoDISCommunication3.36%$595.3M5.2M$114.505+ qtrs▲ Added 6.7%
11Salesforce IncCRMTechnology3.30%$583.6M2.46M$237.005+ qtrs▲ Added 17%
12Autodesk IncADSKTechnology2.99%$528.2M1.66M$317.674 qtrs▼ Reduced 4.7%
13Boston Scientific CorpBSXHealth Care2.62%$463.4M4.75M$97.635+ qtrs▲ Added 19%
14iShares Bitcoin Trust ETFIBIT · SHS BEN INT—2.57%$454.5M6.99M$65.005+ qtrs▼ Reduced 0.4%
15WabtecWABIndustrials2.50%$442.1M2.21M$200.475+ qtrs▲ Added 69%
16Bridgebio Pharma IncBBIOHealth Care2.40%$425.5M8.19M$51.945+ qtrs▲ Added 3.7%
17Protagonist Therapeutics IncPTGXHealth Care2.33%$411.6M6.2M$66.435+ qtrs▲ Added 0.4%
18TransUnionTRUIndustrials2.24%$396.5M4.73M$83.785+ qtrs▼ Reduced 12%
19AramarkARMKConsumer Discretionary1.95%$345.5M9M$38.405+ qtrs▼ Reduced 30%
20IntuitINTUTechnology1.88%$333.3M488.09K$682.915+ qtrs▼ Reduced 9.1%
21
Kellanovano ticker on file
—1.83%$323.5M3.94M$82.024 qtrs▲ Added 124%
22Nasdaq IncNDAQFinancials1.81%$320.5M3.62M$88.455+ qtrs▼ Reduced 11%
23Analog Devices IncADITechnology1.80%$319.3M1.3M$245.705+ qtrs▲ Added 2.2%
24The Charles Schwab CorpSCHWFinancials1.75%$310.4M3.25M$95.474 qtrs▼ Reduced 18%
25New York Times Co MTN BeNYT · CL ACommunication1.62%$286.2M4.99M$57.405+ qtrs▼ Reduced 11%
26Alphabet IncGOOG · CAP STK CL C—1.54%$273M1.12M$243.555+ qtrs▼ Reduced 36%
27CBRE Group IncCBRE · CL AReal Estate1.44%$254.6M1.62M$157.565+ qtrs▼ Reduced 24%
28Mckesson CorpMCKHealth Care1.43%$252.7M327.1K$772.544 qtrs▲ Added 4.0%
29Beam Therapeutics IncBEAM—1.38%$244.2M10.06M$24.275+ qtrs▲ Added 0.5%
30
Crinetics Pharmaceuticalsno ticker on file
—1.36%$240.3M5.77M$41.655+ qtrs▲ Added 24%
31iShares Ethereum Trust ETFETHA · SHS—1.33%$234.8M7.45M$31.511 qtrNew
32Agios Pharmaceuticals IncAGIO—1.31%$232.1M5.78M$40.145+ qtrs▲ Added 0.2%
33Visa IncVFinancials1.16%$204.8M599.81K$341.385+ qtrs▲ Added 94%
34Liquidia CorporationLQDA—1.10%$194.8M8.57M$22.745+ qtrs▲ Added 102%
35Norfolk Southern CorpNSCIndustrials1.04%$184.8M615K$300.411 qtrNew
36Lantheus Holdings IncLNTHHealth Care1.01%$178.3M3.48M$51.295+ qtrs▼ Reduced 48%
37IQVIA Holdings IncIQVHealth Care1.01%$178.3M938.55K$189.945+ qtrs▼ Reduced 76%
38Woodward IncWWDIndustrials0.89%$157.2M621.97K$252.715+ qtrs▼ Reduced 32%
39Mastercard IncMA · CL AFinancials0.69%$121.6M213.77K$568.815+ qtrs▲ Added 41%
40
Centessa Pharmaceuticals PLCno ticker on file · SPONSORED ADS
—0.59%$105M4.33M$24.255+ qtrs▼ Reduced 4.4%
41Teva Pharmaceutical IndustriesTEVA · SPONSORED ADSHealth Care0.57%$100.9M5M$20.201 qtrNew
42Tango Therapeutics IncTNGX—0.51%$90.4M10.76M$8.404 qtrs▲ Added 17%
43Beta Bionics IncBBNX—0.48%$85.7M4.31M$19.873 qtrs▲ Added 2.6%
44Tenet Healthcare CorpTHCHealth Care0.48%$84.1M414K$203.042 qtrs▼ Reduced 22%
45Grail IncGRALHealth Care0.45%$79.8M1.35M$59.132 qtrs▲ Added 169%
46Encompass Health CorpEHCHealth Care0.41%$72.5M571K$127.025+ qtrs▼ Reduced 19%
47Oscar Health IncOSCR · CL AHealth Care0.39%$68.9M3.64M$18.935+ qtrs▲ Added 147%
48Abivax SAABVX · SPONSORED ADSHealth Care0.39%$68.3M805K$84.901 qtrNew
49Mara Holdings IncMARA—0.38%$66.8M3.66M$18.264 qtrs▲ Added 338%
50Mineralys Therapeutics IncMLYS—0.36%$63.4M1.67M$37.921 qtrNew
51Vnet Group IncVNET · SPONSORED ADS A—0.32%$56.7M5.49M$10.335+ qtrs▲ Added 83%
52
Cidara Therapeutics Incno ticker on file
—0.28%$48.6M508K$95.762 qtrs▲ Added 154%
53Grayscale Coindesk CryptoGDLC · USD SHS—0.27%$47.6M851.19K$55.901 qtrNew
54
MR Cooper Group Incno ticker on file
—0.26%$46.8M222K$210.792 qtrs▲ Added 81%
55Nektar TherapeuticsNKTR—0.25%$45M791K$56.901 qtrNew
56Cardinal Health IncCAHHealth Care0.22%$39.7M253K$156.963 qtrs▼ Reduced 44%
57JOYY IncJOYY · ADS REPSTG COM A—0.21%$36.6M625K$58.613 qtrs▼ Reduced 21%
58Flutter Entertainment PLCFLUT · SHSTechnology0.20%$34.9M137.37K$254.005+ qtrs▼ Reduced 24%
59Uniqure NVQURE · SHS—0.19%$33M565K$58.373 qtrs▲ Added more than 10×
60Assembly Biosciences IncASMB—0.18%$31.4M1.23M$25.601 qtrNew
61New Oriental ED & TechnologyEDU · SPON ADRConsumer Discretionary0.17%$30M565.15K$53.075+ qtrs▼ Reduced 51%
62Waystar Holding CorpWAYTechnology0.16%$28.4M750K$37.924 qtrs▲ Added 22%
63Baidu IncBIDU · SPON ADR REP ATechnology0.16%$27.4M208K$131.771 qtrNew
64Doximity IncDOCS · CL ATechnology0.16%$27.4M374K$73.151 qtrNew
65Prime Medicine IncPRME—0.15%$26.3M4.75M$5.545+ qtrs▲ Added 533%
66Enanta Pharmaceuticals IncENTA—0.14%$25.4M2.12M$11.975+ qtrsNo change
67Surgery Partners IncSGRY—0.11%$18.9M871.83K$21.642 qtrs▼ Reduced 55%
68Tyra Biosciences IncTYRA—0.09%$16M1.14M$13.994 qtrsNo change
69Intellia Therapeutics IncNTLA—0.06%$10.5M607.2K$17.271 qtrNew
70
Soleno Therapeutics Incno ticker on file
—0.06%$10.3M153K$67.604 qtrs▲ Added more than 10×
71Tectonic Therapeutic IncTECX—0.06%$10M640K$15.695+ qtrs▼ Reduced 25%
72Savara IncSVRA—0.05%$8.9M2.5M$3.575+ qtrs▼ Reduced 63%
73Novavax IncNVAX—0.04%$6.8M780K$8.675+ qtrs▲ Added more than 10×
74Schrodinger IncSDGR—0.03%$5.7M284K$20.062 qtrs▼ Reduced 74%
75
iShares Trustno ticker on file · ISHARES SEMICDTR
—0.03%$5.1M18.91K$271.121 qtrNew
76
Allete Incno ticker on file
—0.03%$5M75K$66.401 qtrNew
77Tvardi Therapeutics IncTVRD—0.01%$1.7M43.23K$38.972 qtrsNo change
78Alvotech SAALVO · ORDINARY SHARES—0.01%$1.6M199.68K$8.195+ qtrsNo change
79Madrigal Pharmaceuticals IncMDGLHealth Care0.01%$1.5M3.32K$458.665+ qtrsNo change
80Summit Midstream CorporationSMC—0.01%$1.2M58.21K$20.545+ qtrsNo change
81Brightspring Health Services IncBTSGHealth Care0.00%$650.3K22K$29.565+ qtrsNo change
82Alkermes PLCALKS · SHSHealth Care0.00%$624K20.8K$30.003 qtrs▼ Reduced 97%
83Roivant Sciences LtdROIV · SHSHealth Care0.00%$559.8K37K$15.135+ qtrsNo change
84Arrowhead PharmaceuticalsARWRHealth Care0.00%$544.9K15.8K$34.494 qtrsNo change
85GeneDx Holdings CorpWGS—0.00%$538.7K5K$107.744 qtrs▼ Reduced 98%
86Guardant Health IncGHHealth Care0.00%$499.8K8K$62.482 qtrsNo change
87Arcutis Biotherapeutics IncARQT—0.00%$490.1K26K$18.855+ qtrsNo change
88Axsome Therapeutics IncAXSMHealth Care0.00%$485.8K4K$121.455+ qtrsNo change
89Healthequity IncHQYHealth Care0.00%$473.9K5K$94.775+ qtrs▼ Reduced 98%
90Insmed IncINSMHealth Care0.00%$432K3K$144.015+ qtrsNo change
91Progyny IncPGNY—0.00%$387.4K18K$21.525+ qtrsNo change
92Beone Medicines LtdONC · SPONSORED ADSHealth Care0.00%$374.8K1.1K$340.705+ qtrsNo change
93Krystal Biotech IncKRYSHealth Care0.00%$353.1K2K$176.535+ qtrsNo change
94
Arcellx Incno ticker on file
—0.00%$328.4K4K$82.105+ qtrsNo change
95CG Oncology IncCGONHealth Care0.00%$322.2K8K$40.282 qtrsNo change
96Livanova PLCLIVN · SHSHealth Care0.00%$314.3K6K$52.383 qtrsNo change
97Ionis Pharmaceuticals IncIONSHealth Care0.00%$314K4.8K$65.421 qtrNew
98Cencora IncCORHealth Care0.00%$312.5K1K$312.535+ qtrsNo change
99Capricor Therapeutics IncCAPR—0.00%$295.6K41K$7.214 qtrsNo change
100Travere Therapeutics IncTVTXHealth Care0.00%$286.8K12K$23.902 qtrsNo change
101
Merus N Vno ticker on file
—0.00%$282.5K3K$94.151 qtrNew
102Grifols S AGRFS · SP ADR REP B NVTHealth Care0.00%$278.9K28K$9.965+ qtrsNo change
103Ascendis Pharma A/SASND · SPONSORED ADRHealth Care0.00%$278.3K1.4K$198.813 qtrsNo change
104Sabra Health Care REIT IncSBRAReal Estate0.00%$261K14K$18.645+ qtrsNo change
105Scholar Rock Holding CorpSRRKHealth Care0.00%$260.7K7K$37.244 qtrsNo change
106
Nuvalent Incno ticker on file
—0.00%$259.4K3K$86.485+ qtrs▼ Reduced 98%
107Merit Med Systems IncMMSIHealth Care0.00%$249.7K3K$83.235+ qtrsNo change
108Cogent Biosciences IncCOGTHealth Care0.00%$244.1K17K$14.365+ qtrsNo change
109Veracyte IncVCYT—0.00%$240.3K7K$34.331 qtrNew
110Globus Med IncGMED · CL AHealth Care0.00%$229.1K4K$57.275+ qtrs▼ Reduced 98%
111
Aleanna Incno ticker on file · *W EXP 12/13/202
—0.00%$225.7K990K$0.22804 qtrsNo change
112GE HealthCare Technologies IncGEHCHealth Care0.00%$225.3K3K$75.104 qtrs▼ Reduced 100%
113Mirum Pharmaceuticals IncMIRMHealth Care0.00%$219.9K3K$73.311 qtrNew
114UroGen Pharma LtdURGN—0.00%$219.5K11K$19.951 qtrNew
115Healthcare Realty TrustHR · CL A COMReal Estate0.00%$216.4K12K$18.035+ qtrsNo change
116Twist Bioscience CorpTWSTHealth Care0.00%$215.3K7.65K$28.145+ qtrsNo change
117Glaukos CorpGKOSHealth Care0.00%$212K2.6K$81.555+ qtrsNo change
118Ultragenyx PharmaceuticalRARE—0.00%$210.6K7K$30.082 qtrs▼ Reduced 99%
119Icon Pub Ltd CoICLR · SHSHealth Care0.00%$210K1.2K$175.001 qtrNew
120Immunovant IncIMVTHealth Care0.00%$193.4K12K$16.125+ qtrsNo change
121BioCryst Pharmaceuticals IncBCRX—0.00%$182.2K24K$7.591 qtrNew
122Pacific Biosciences of California IncPACB—0.00%$172.8K135K$1.285+ qtrsNo change
123
Solid Power Incno ticker on file · *W EXP 12/08/202
—0.00%$168.4K405.32K$0.41555+ qtrsNo change
124Syndax Pharmaceuticals IncSNDX—0.00%$153.9K10K$15.395+ qtrsNo change
125
Blue Gold Ltdno ticker on file · *W EXP 04/01/203
—0.00%$137.3K300K$0.45761 qtrNew
126Ardelyx IncARDX—0.00%$126.7K23K$5.515+ qtrsNo change
127Dyne Therapeutics IncDYN—0.00%$126.5K10K$12.655+ qtrsNo change
128
Amicus Therapeuticno ticker on file
—0.00%$126.1K16K$7.885+ qtrsNo change
129Evolent Health IncEVH · CL A—0.00%$118.4K14K$8.465+ qtrsNo change
130Altimmune IncALT—0.00%$104.1K27.6K$3.775+ qtrsNo change
131C4 Therapeutics IncCCCC—0.00%$62.2K28K$2.225+ qtrsNo change
132
Aleanna Incno ticker on file
—0.00%$61.8K78.4K$0.78854 qtrsNo change
133Geron CorpGERN—0.00%$58.9K43K$1.375+ qtrsNo change
134Iovance Biotherapeutics IncIOVA—0.00%$56.4K26K$2.175+ qtrsNo change
135Canopy Growth CorporationCGC—0.00%$43.8K30K$1.465+ qtrsNo change
136
Revolution Medicines Incno ticker on file · *W EXP 12/17/202
—0.00%$36K120.09K$0.30005+ qtrsNo change
137Beyond Meat IncBYND—0.00%$35.9K19K$1.895+ qtrsNo change
138
Nvni Group Limitedno ticker on file · *W EXP 11/01/202
—0.00%$27K375K$0.07205+ qtrsNo change
139Ironwood Pharmaceuticals IncIRWD—0.00%$17K13K$1.315+ qtrsNo change

By sector

Andrew Spokes portfolio by sector, Q3 2025
SectorShare of portfolioValuePositions
Health Care36.6%$6.5B47
Technology16.2%$2.9B9
Financials10.00%$1.8B5
Industrials6.67%$1.2B4
Consumer Discretionary6.47%$1.1B3
Communication4.98%$881.5M2
Real Estate1.44%$255.1M3
No sector on file17.6%$3.1B66

Questions and answers

What did Andrew Spokes own in Q3 2025?

Farallon Capital Management's 13F for Q3 2025 lists 139 positions worth $17.7B. The largest: MSFT (5.6%), AON (4.6%), EXEL (4.6%), AMZN (4.3%), NTRA (3.9%).

What did Andrew Spokes buy in Q3 2025?

The largest purchases, by the shares bought at the quarter-end price the filing implies: ETHA (new, $234.8M), NSC (new, $184.8M), WAB (added, $179.8M), Kellanova (added, $178.9M), HIMS (added, $143.7M), EXEL (added, $143.1M).

What did Andrew Spokes sell in Q3 2025?

The largest sales: SPY (sold out, $3.4B), Hess Corp (sold out, $804.2M), IQV (reduced, $553.3M), Liberty Broadband Corp (sold out, $420.5M), ANSYS Inc (sold out, $350.2M), Verona Pharma Plc (sold out, $171.2M).

When was this filing made?

Farallon Capital Management filed its 13F for the quarter ending Sep 30, 2025 on Nov 14, 2025, and amended it on Feb 17, 2026; the figures here include the amendment. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

Learn

Cite this page

Funkfolio, “Andrew Spokes portfolio, Q3 2025: Farallon Capital Management 13F holdings”, data as of 17 February 2026. https://funkfolio.com/gurus/farallon/2025-q3

Underlying data: SEC EDGAR, Form 13F-HR of Farallon Capital Management (CIK 909661) for the period ending Sep 30, 2025.

Source: SEC EDGAR, Form 13F-HR for Farallon Capital Management (CIK 909661), period ending Sep 30, 2025, filed Nov 14, 2025, amended Feb 17, 2026. Changes compare share counts with the filing for Jun 30, 2025; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $17.7B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 5 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. 5 option positions in the filing are not shown. Not a live portfolio and not advice.